19-42402121-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005357.4(LIPE):c.2968-46G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.098 in 1,420,750 control chromosomes in the GnomAD database, including 7,656 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.082 ( 649 hom., cov: 31)
Exomes 𝑓: 0.10 ( 7007 hom. )
Consequence
LIPE
NM_005357.4 intron
NM_005357.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0160
Genes affected
LIPE (HGNC:6621): (lipase E, hormone sensitive type) The protein encoded by this gene has a long and a short form, generated by use of alternative translational start codons. The long form is expressed in steroidogenic tissues such as testis, where it converts cholesteryl esters to free cholesterol for steroid hormone production. The short form is expressed in adipose tissue, among others, where it hydrolyzes stored triglycerides to free fatty acids. [provided by RefSeq, Jul 2008]
LIPE-AS1 (HGNC:48589): (LIPE antisense RNA 1)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 19-42402121-C-G is Benign according to our data. Variant chr19-42402121-C-G is described in ClinVar as [Benign]. Clinvar id is 1234041.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0825 AC: 12546AN: 152074Hom.: 653 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
12546
AN:
152074
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.121 AC: 5185AN: 42746 AF XY: 0.123 show subpopulations
GnomAD2 exomes
AF:
AC:
5185
AN:
42746
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0998 AC: 126655AN: 1268558Hom.: 7007 Cov.: 34 AF XY: 0.102 AC XY: 62769AN XY: 614198 show subpopulations
GnomAD4 exome
AF:
AC:
126655
AN:
1268558
Hom.:
Cov.:
34
AF XY:
AC XY:
62769
AN XY:
614198
Gnomad4 AFR exome
AF:
AC:
758
AN:
25152
Gnomad4 AMR exome
AF:
AC:
2730
AN:
18908
Gnomad4 ASJ exome
AF:
AC:
1642
AN:
18256
Gnomad4 EAS exome
AF:
AC:
920
AN:
29772
Gnomad4 SAS exome
AF:
AC:
11379
AN:
60978
Gnomad4 FIN exome
AF:
AC:
3004
AN:
42778
Gnomad4 NFE exome
AF:
AC:
100181
AN:
1016384
Gnomad4 Remaining exome
AF:
AC:
5303
AN:
52434
Heterozygous variant carriers
0
6218
12436
18653
24871
31089
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
3900
7800
11700
15600
19500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0823 AC: 12532AN: 152192Hom.: 649 Cov.: 31 AF XY: 0.0842 AC XY: 6263AN XY: 74410 show subpopulations
GnomAD4 genome
AF:
AC:
12532
AN:
152192
Hom.:
Cov.:
31
AF XY:
AC XY:
6263
AN XY:
74410
Gnomad4 AFR
AF:
AC:
0.0318232
AN:
0.0318232
Gnomad4 AMR
AF:
AC:
0.124641
AN:
0.124641
Gnomad4 ASJ
AF:
AC:
0.0913545
AN:
0.0913545
Gnomad4 EAS
AF:
AC:
0.0406347
AN:
0.0406347
Gnomad4 SAS
AF:
AC:
0.194905
AN:
0.194905
Gnomad4 FIN
AF:
AC:
0.0739623
AN:
0.0739623
Gnomad4 NFE
AF:
AC:
0.0985582
AN:
0.0985582
Gnomad4 OTH
AF:
AC:
0.0919431
AN:
0.0919431
Heterozygous variant carriers
0
570
1141
1711
2282
2852
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
402
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 20, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at